DaVita
DVA
#1636
Rank
NZ$23.00 B
Marketcap
NZ$358.38
Share price
-0.37%
Change (1 day)
56.50%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$18.80

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$18.86. In 2025 the company made an earnings per share (EPS) of NZ$17.35 a decrease over its 2024 EPS that were of NZ$18.92.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$18.808.32%
2025NZ$17.35-8.25%
2024NZ$18.9244.94%
2023NZ$13.0527.26%
2022NZ$10.26-35.56%
2021NZ$15.9144.1%
2020NZ$11.0419.7%
2019NZ$9.23540.48%
2018NZ$1.44-76.07%
2017NZ$6.02-19.31%
2016NZ$7.46242.52%
2015NZ$2.18-62.87%
2014NZ$5.8613.43%
2013NZ$5.178.45%
2012NZ$4.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$41.69 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.48 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$33.35 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.31-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA